Lymphogranuloma venereum in Australia. 1. Clinical aspects of the disease and isolation and identification of the causal agent from a patient in Melbourne.
D000328:Adult; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial; D001315:Australia; D001706:Biopsy; D001921:Brain / Q000382:microbiology; D002642:Chick Embryo; D002689:Chlamydia / Q000276:immunology / Q000302:isolation & purification* / Q000472:pathogenicity; D003168:Complement Fixation Tests; D005455:Fluorescent Antibody Technique; D006801:Humans; D008198:Lymph Nodes / Q000382:microbiology; D008219:Lymphogranuloma Venereum / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D008297:Male; D051379:Mice; D009500:Neutralization Tests; D013449:Sulfonamides / Q000627:therapeutic use; D013588:Syphilis Serodiagnosis; D013752:Tetracycline / Q000627:therapeutic use
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D013449:Sulfonamides; D013752:Tetracycline